Skip to main content
Cellular and Molecular Immunology logoLink to Cellular and Molecular Immunology
letter
. 2014 Nov 3;12(4):513–514. doi: 10.1038/cmi.2014.96

‘Hot stuff': inflammatory lymphocyte populations in acute coronary syndrome

Natale Daniele Brunetti 1
PMCID: PMC4496547  PMID: 25363525

Acute myocardial infarction and coronary unstable plaque: definitely ‘hot stuff' to address. However, it is not just a pun. Atherosclerosis and acute coronary syndrome are both characterized by active inflammation.1 Increased levels of C-reactive protein and inflammatory cytokines have been found during the very early phases of acute myocardial infarction2 and are associated with a worse prognosis.1

The immune system also participates in almost every phase of atherosclerotic disease.3 There is increasing evidence that both adaptive and innate immunity tightly regulate atherogenesis. Adaptive immune populations, particularly T cells, regulate the magnitude of the pro-inflammatory atherogenic response. Immune-mediated processes are involved during the onset, development and rupture of coronary plaques, where the presence of activated T lymphocytes was demonstrated decades ago.4 CD4+, and to a lesser extent CD8+ T cells, localize in atherosclerotic plaques. T cells also influence the stability of the atherosclerotic lesion and thus the propensity for thrombus formation and the clinical outcome of disease. T-cell responses observed in patients with unstable angina are antigen-driven and directed against antigens contained in coronary atherosclerotic plaques.5 Patients with unstable angina are characterized by a perturbation of the functional T-cell repertoire with a bias toward interferon-gamma production, suggesting that monocyte activation and acute phase responses are consequences of T-cell activation.6 Interferon-gamma is produced by CD4+CD28null T cells, which are expanded in patients with unstable angina yet demonstrably low in patients with stable angina and controls. Several novel CD4+ T-cell subsets, including Th9 cells and Th17 cells, have recently been identified during the progression of coronary atherosclerosis.

Early atherosclerosis is particularly influenced by lymphocyte activity. When atherosclerosis-prone (LDLR−/−) mice were crossed with lymphocyte-deficient (RAG1−/−) mice to generate double knockout progeny, lesion development was reduced by 54% in double knockout mice compared with matched LDLR−/− controls.7 Transfer of CD4+ T cells from apoE−/− to immunodeficient apoE−/−/scid/scid mice increased atherosclerotic lesions by 164%.8 This increase was associated with the infiltration of transferred T cells into lesions, thus indicating that CD4+ T cells promote disease during atherosclerosis.

Particular reservoirs of T cells seem to be associated with early aggressive forms of coronary atherosclerosis. In small studies, non-diabetic patients with early clinical presentation of coronary heart disease showed lower CD3+CD8+ levels, whereas their CD4+ populations were higher9. Additionally, CD8+ levels were inversely related to the severity of coronary atherosclerosis. CD4+CD28null T cells were expanded in patients with unstable angina and infrequent in patients with stable angina.10 A patient's CD4+CD28null T-cell frequency was shown to be an independent predictor of future acute coronary events.

However, we must acknowledge that are we are moving into very poorly charted territories. You, Yun and colleagues shed light on this topic with their recent paper. Interestingly, the frequency of CD57+ cells in the CD8+ T-cell population was found to correlate not only with cytokine activation but also with a ‘hard' clinical outcome such as cardiovascular mortality 6 months after acute myocardial infarction. The authors note that the expression of the CD57 epitope on T cells may be a surrogate marker of replicative senescence. Beyond any value in risk stratification of acute coronary syndrome, analysis of such a lymphocyte population offers a potential therapeutic strategy via modification of T-cell responses.

Indeed, many additional studies are needed before a clear and complete understanding of the inflammatory and lymphocyte connections implied in the progression of atherosclerosis and the clinical onset of acute coronary syndrome can be achieved. ‘Hot' topic, ‘hot' stuff, ‘cool' studies to be done.

References

  1. Brunetti ND, Troccoli R, Correale M, Pellegrino PL, Di Biase M. C-reactive protein in patients with acute coronary syndrome: correlation with diagnosis, myocardial damage, ejection fraction and angiographic findings. Int J Cardiol. 2006;109:248–256. doi: 10.1016/j.ijcard.2005.06.021. [DOI] [PubMed] [Google Scholar]
  2. Brunetti ND, Munno I, Pellegrino PL, Ruggero V, Correale M, de Gennaro L, et al. Inflammatory cytokines imbalance in the very early phase of acute coronary syndrome: correlations with angiographic findings and in-hospital events. Inflammation. 2011;34:58–66. doi: 10.1007/s10753-010-9208-1. [DOI] [PubMed] [Google Scholar]
  3. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol. 2006;6:508–519. doi: 10.1038/nri1882. [DOI] [PubMed] [Google Scholar]
  4. Hansson GK, Holm J, Jonasson L. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am J Pathol. 2989;135:169–175. [PMC free article] [PubMed] [Google Scholar]
  5. Caligiuri G, Paulsson G, Nicoletti A, Maseri A, Hansson GK. Evidence for antigen-driven T-cell response in unstable angina. Circulation. 2000;102:1114–1119. doi: 10.1161/01.cir.102.10.1114. [DOI] [PubMed] [Google Scholar]
  6. Liuzzo G, Kopecky SL, Frye RL, O'Fallon WM, Maseri A, Goronzy JJ, et al. Perturbation of the T-cell repertoire in patients with unstable angina. Circulation. 1999;100:2135–2139. doi: 10.1161/01.cir.100.21.2135. [DOI] [PubMed] [Google Scholar]
  7. Song L, Leung C, Schindler C. Lymphocytes are important in early atherosclerosis. J Clin Invest. 2001;108:251–259. doi: 10.1172/JCI11380. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Zhou X, Nicoletti A, Elhage R, Hansson GK. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation. 2000;102:2919–2922. doi: 10.1161/01.cir.102.24.2919. [DOI] [PubMed] [Google Scholar]
  9. Brunetti ND, D'Antuono C, Rana M, D'Arienzo G, de Gennaro L, Di Biase M. Lymphocyte subset characterization in patients with early clinical presentation of coronary heart disease. J Thromb Thromb. 2012;34:475–482. doi: 10.1007/s11239-012-0761-3. [DOI] [PubMed] [Google Scholar]
  10. Liuzzo G, Goronzy JJ, Yang H, Kopecky SL, Holmes DR, Frye RL, et al. Monoclonal T-cell proliferation and plaque instability in acute coronary syndromes. Circulation. 2000;101:2883–2888. doi: 10.1161/01.cir.101.25.2883. [DOI] [PubMed] [Google Scholar]

Articles from Cellular and Molecular Immunology are provided here courtesy of Nature Publishing Group

RESOURCES